SCHEMBL6019666

SCHEMBL6019666

CC(C)(C)OC(=O)N(CCCC[C@H](NC(=O)c1ccc(CNC(=O)OCc2ccccc2)cc1)C(=O)O)Cc1ccccn1.NCc1cccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 4/20 0.43
PRSS2 P07478 4/20 0.43
PRSS3 P35030 4/20 0.43
TPSAB1 Q15661 4/20 0.43
HDAC1 Q13547 3/20 0.42
HDAC2 Q92769 2/20 0.42
CXCR4 P61073 1/20 0.41
TGM2 P21980 1/20 0.39
KCNA5 P22460 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
POLB P06746 1/20 0.36
GPR55 Q9Y2T6 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGAV P06756 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNA3 P22001 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018196 0.92 CXCR4 (0.43) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6019678 0.84 CXCR4 (0.46) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6018386 0.84 CXCR4 (0.48) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6018874 0.80 CXCR4 (0.39) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6690903 0.79 CXCR4 (0.41) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6689236 0.79 CXCR4 (0.40) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6019453 0.77 HDAC3 (0.47) HDAC1HDAC2CXCR4CA1CA2
SCHEMBL6018088 0.74 HDAC3 (0.48) HDAC1HDAC2CXCR4
SCHEMBL6018262 0.74 CXCR4 (0.57) PRSS1PRSS2PRSS3TPSAB1HDAC1
SCHEMBL6655796 0.72 CXCR4 (0.59) HDAC1HDAC2CXCR4FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7098215-B2 Nitrogenous compounds and antiviral drugs containing the same KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 2006-08-29 US disclosed
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound KUREHA CORPORATION (JP) 2004-08-12 US disclosed
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same KUREHA CORPORATION (JP) 2004-05-13 US disclosed
EP-1389460-A1 CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND Kureha Chemical Industry Co., Ltd. (JP) 2004-02-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092556-A1 Nitrogenous compounds and antiviral drugs containing the same NSUN2, ZC3HAV1L, PNP PRSS1 3563/4885PRSS2 3984/4885PRSS3 4253/4885
US-20040157818-A1 Cxcr4-antagonistic drugs composed of nitrogen-containing compound CXCR4, CXCR1, CXCR2 PRSS1 4401/4885PRSS2 4719/4885PRSS3 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.